Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
일요일, 8월 30

National Health Investors Inc

NHINYSE
Trade with Public
Trade with Public
$72.03
-0.53-0.73%
가까이에: Aug 28, 5:00 PM EST
$72.03
N/A
시간외: Aug 28, 4:00 PM EST
개요뉴스실적 전망목표가재무심리지분 현황배당금비교옵션주식 보고서

National Health Investors Financials

National Health Investors (NHI) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
National Health Investors Affirms FY2026 FFO Guidance of $4.74-$4.79 vs $4.84 Est

National Health Investors (NYSE:NHI) affirms FY2026 FFO guidance from $4.74-$4.79 to $4.74-$4.79 vs $4.84 analyst estimate..
Benzinga Newsdesk

PRO
National Health Investors Q2 FFO $1.19 Misses $1.26 Estimate, Sales $121.319M Beat $111.677M Estimate

National Health Investors (NYSE:NHI) reported quarterly earnings of $1.19 per share which missed the analyst consensus estimate of $1.26 by 5.56 percent. This is a 2.46 percent decrease over earnings of $1.22 per share
Benzinga Newsdesk

PRO
National Health Investors Sees FY26 NAREIT FFO $4.74-$4.79 Vs $4.94-$4.99 Prior

Normalized FFO per diluted share from a range of $4.94 - $4.99 to a range of $4.74 - $4.79; and Normalized FAD from a range of $248.9 million - $251.4 million to a range of $240.6 million - $243.7 million.
Benzinga Newsdesk

PRO
National Health Investors Q1 FFO $1.23 Beats $1.22 Estimate, Sales $115.130M Beat $105.353M Estimate

National Health Investors (NYSE:NHI) reported quarterly earnings of $1.23 per share which beat the analyst consensus estimate of $1.22 by 0.82 percent. This is a 6.96 percent increase over earnings of $1.15 per share
Benzinga Newsdesk

Earnings Scheduled For May 4, 2026

Benzinga Insights

PRO
National Health Investors Sees FY2026 FFO $4.94-$4.99 vs $5.12 Est

National Health Investors (NYSE:NHI) is looking for FY2026 FFO of $4.94-$4.99 vs $5.12 analyst estimate..
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved